financial toxicity

medication adherence

Mental health monitoring

thyroid function, thyroid controls so many aspects of the human body and can cause a wide array of sometimes vague symptoms and a simple TSH, free T3/T4 could diagnose hypo/hyper thyroidism

BP monitoring is critical to detect wide excursions and treat appropriately to reduce morbidity

BP management as there are lot of pts who need to be less than 130/80 and it is challenging to titrate the meds and the life style modification

Caloric and protein intake.

Monitoring labs especially in inflammatory bowel disease with advanced biologic therapy.

Weight loss management and routine checkups

Since there are new tests to predict the onset of pregnancy induced hypertension that information should be more widely disseminated to all ob providers.

Nutrition in pediatrics need to be addressed to prevent obesity, not just waiting to treat it when it’s already a problem. Public health measures for healthy foods needs more support.

I often see patients lacking hemograms or lipid profiles for 1-2 years when referred

Medication interactions deserves more attention.

I think less monitoring is becoming the trend in dermatology, such as less labs for accutane patients, not routinely checking potassium levels for young healthy females on spironolactone, less TB testing with biologics

I think proper inhaler device usage is often a problem. I will often will demonstrate inhaler technique especially for patients who have ongoing symptoms despite their inhaled medication or report little benefit when using their short acting beta agonist.

Inhaler use esp albuterol. How often they are refilling, what symptoms they are using it for etc

Drug interactions and the relative danger of medication use in those over 65 years, i.e. Beers Criteria

Drug interactions. Thanksfully the electronic medical record helps with this. But it is important to verify a patients meds and allergies even after staff has already roomed the patient and entered this info.

medication adherence

I think we massively under-monitor adherence. A simple, routine way to capture how often patients actually use what we prescribe would probably explain half of our “non‑responders.”

Inhaler technique monitoring or systemic inflammation markers in COPD

Biomarkers to monitor treatment response and prognosis.

I think OCT monitoring of macular edema and glaucoma gets plenty of deserved attention, and has changed the practice of ophthalmology in a profound way.

To improve better Communication between patients and their family. Also, need to get insurance companies to include this this in their wellness programs to lower costs and improve compliance.

Peak flow monitoring at home for asthma is archaic Home nitro oxide monitoring never took off due to the cost. Wearable devices may give you information about SPO2, but not the equivalent of spirometric evaluations.

Addressing weight loss management

In general, close follow up in any condition to ascertain a patient is, for example, taking a new medication properly and consistently is important. And example is chronic constipation in kids - almost universally parents will stop meds within a short amt of time if they thing their kid is doing better.

I feel that when I was doing cardiology that after the regular office closed for the day, one day a week after hours we could hold an arrhythmia clinic and another day a chf clinic to go over treatment options, review current therapies or therapy changes and prevent hospitalizations especially 30 day re-admissions because these subsets are being seen more frequently and we all know that chf re-admission is a huge issue

A regular joint exam to monitor RA treatment response.

Communication between patients especially elderly and their family

Actually talking to patients and examining them. Also talking to a significant other if the patient brings that person to the appointment. Also seeing via pharmacy refills if the patient is complaint with his/her meds.

remote data monitoring/data collection, especially in oncology pateints

management of areas that are of high risk to patients for morbidity/mortality: Postpartum hemorrhage: recognition, diagnosis and prompt treatment; hypertensive disorders of pregnancy (same three issues), maternal and gyn sepsis (same three issues). Use of new surgical modalities (proper training, credentialing and maintenance of skills)

pre natal

In ID, Viral studies, STI's, Tick Borne, Travel Hx, Etc
and anything considered Infectious

In pathology, our equivalent of treatment monitoring might be results return to patients. It's common today for results to be returned over a portal - patients may see their surgical pathology result on their phone before they hear it from their physician. It's an unfortunate corollary of the 21st Century Cures Act (otherwise well intentioned). This isn't good medicine. It would be great for our society to consider better alternatives for clear communication of results.

albumin creatinine ratio

Accurate urine output measurement over time

Neurological exam. It is important to do serial exams for many of the conditions I treat to assess effects of treatment

Lipids, more stringent control of B.P. and proteinuria.

Urine Micorlabumin Creatinine ratio needs to be done more often in pts at risk for CVD as microalbuminuria is a sginficant risk factor , Lpa and Coronary Artery Calcium score needs more attention for Risk Startifcation for CVD , HTN with target for Less than 130/80 needs to be aimed at

We need to monitor the patient’s social situation, looking for stressors and particularly potential abuse, often mental, not physical.

Monitoring lipids and cardiovascular risk in patients - esp those w strong family history / risk

Increased emphasis on monitoring off ongoing smoking aand former smoking patiient''s with yearly low-dose lung ccancer screening CTs-undeer utilized, the morre education and advertisemmenttt for this potentially life-saviing procedure.

Monitoring for side effects of the new biologics. The abrupt change to biologics has been dramatic.

monitoring of metabolic labs

I believe the 'human interaction' i.e. seeing one's patient at regular intervals (in addition to monitoring essential laboratory values) is the most important aspect that needs the respect and attention which it is not given in the way we practice in this day and age.

ADHD response to meds is still very subjective

Type 2 diabetes and weight loss

Any patient with hypertension needs to make sure they do not have hyperaldosteronism with a renin/aldosterone level

It is highly important to check the blood levels of pscych meds ND SEE IF THEY ARE WORKING.

All of my pts with neuro dz needs better monitor for a lot it is simple pt recount but without a standarized measure

We need to have a proven system where there is seamless professional care for the newborn through to at least age 2yrs. Currently big hospital groups who are trying to keep patients in their system make it a little difficult for independent groups/clinics to get information on the patient which is needed for continuity of care. Monitoring of pediatric patients under the medical home concept should be improved. Some of these kids are not made to return to their medical home during the time of treatment under these subspecialties. Medical insurance companies as well as subspecialty providers should improve in this area.

Blood levels for psychiatric patients who do not appear to be adherent to their medications

Compliance with prevention of kidney stones.
Better patient control

Motivational interviewing for victims of trauma, physical or sexual

Mental health as so many patients have mental health issues, including anxiety and depression, and skin disease exacerbates anxiety.

Mental health care for cancer survivors

Over testing and treatment of cervical dysplasia.

GLP-1s is a huge one

Laboratory monitoring in patients with advanced biologic therapy for inflammatory bowel disease

orthobioligics for pain management

monitoring of Biologics and vaccination history

I actually think less monitoring is needed for example TB tests for biologics, monthly labs for accutane, potassium for spironolactone etc

Use of molecular techniques for assessing minimal residual disease (MRD).

De conditioning in oncology. We are good on focusing on counts, N/V, infection risk , bleeding etc. But as metastatic cancer has a longer survival time, we are seeing patients that have decreasing performance status over time.

Patients adherence to medications , particularly for patients with heart failure who are frequently admitted to hospitals for de compensation.

I would be interested to have a randomized studies to determine whether electronic remote monitoring of patients improve quality of life, survival rate, and lead to early detection of significant events such as bacteremia/sepsis, dehydration, etc. in oncology

Integrating Patient-Reported Outcomes (PROs) with Remote Patient Monitoring (RPM) shifts nephrology from reactive to proactive care. While creatinine is a lagging indicator, PROs capture "soft biomarkers"—like fatigue or pruritus—that signal friction before physiological decline. Paired with real-time RPM data like bioimpedance, clinicians can catch subclinical instability early, transforming the care plan into a dynamic strategy that prioritizes both organ preservation and quality of life.

Using cDNA to monitor treatment response and early detection of recurrence disease

my field, we tend to monitor laboratory and disease-specific targets very closely, but we under-monitor functional status, treatment burden, and patient-centered outcomes. Especially in older or multimorbid patients, changes in mobility, cognition, and quality of life often provide earlier and more meaningful signals than biomarkers alone. I think integrating structured functional and frailty assessments into routine monitoring would significantly improve care quality.

Lp(a) as part of the lipid panel is not ordered by PCPs

Thyroglobulin level in thyroid cancer is something most non-Endocrinologists overlook.